HomeMBX • NASDAQ
add
MBX Biosciences Inc
Previous close
$28.00
Day range
$29.20 - $31.20
Year range
$4.81 - $44.89
Market cap
1.44B USD
Avg Volume
653.96K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 25.80M | 38.61% |
Net income | -22.06M | -41.55% |
Net profit margin | — | — |
Earnings per share | -0.49 | -4.26% |
EBITDA | -25.74M | -38.72% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 373.70M | 42.55% |
Total assets | 385.14M | 43.42% |
Total liabilities | 15.92M | 43.52% |
Total equity | 369.22M | — |
Shares outstanding | 47.51M | — |
Price to book | 3.41 | — |
Return on assets | -16.43% | — |
Return on capital | -17.02% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -22.06M | -41.55% |
Cash from operations | -18.30M | -14.12% |
Cash from investing | -129.97M | -93.00% |
Cash from financing | 438.00K | 431.82% |
Net change in cash | -147.84M | -77.02% |
Free cash flow | -12.69M | -14.51% |
About
Founded
2018
Headquarters
Website
Employees
63
